FIELD: medicine.
SUBSTANCE: present invention relates to a novel imidazole derivative having C-Jun N-terminal kinase (JNK) activity and use thereof.
EFFECT: novel imidazole derivative or a pharmaceutically acceptable salt thereof according to the present invention exhibits excellent C-Jun N-terminal kinase (JNK) activity and thus it is expected that a more fundamental approach and targeted treatment will be possible in preventing or treating degenerative diseases of the nervous system of the brain.
12 cl, 3 tbl, 37 ex
| Title | Year | Author | Number |
|---|---|---|---|
| GEMINALLY SUBSTITUTED CYANOETHYLPYRAZOLO PYRIDONES AS JANUS KINASE INHIBITORS | 2014 |
|
RU2664533C2 |
| INHIBITOR COMPOUNDS | 2013 |
|
RU2673079C2 |
| BICYCLIC COMPOUND AND USE THEREOF FOR SUV39H2 INHIBITION | 2016 |
|
RU2729187C1 |
| AMINOTRIAZOLOPYRIDINES AND USING THEM AS KINASE INHIBITORS | 2009 |
|
RU2552642C2 |
| AZABICYCLOCOMPOUND AND ITS SALT | 2010 |
|
RU2565078C2 |
| AMINOPYRIMIDINE DERIVATIVES AND USE THEREOF AS AROMATIC HYDROCARBON RECEPTOR MODULATORS | 2021 |
|
RU2826628C1 |
| DERIVATIVES OF N-(SUBSTITUTED PHENYL)-SULFONAMIDE AS KINASE INHIBITORS | 2017 |
|
RU2753520C2 |
| QUINOLINE DERIVATIVES AND MELK INHIBITORS CONTAINING SAME | 2011 |
|
RU2582610C2 |
| 6-[4-(1H-IMIDAZOL-2-YL)PIPERIDIN-1-YL]PYRIMIDIN-4-AMINE DERIVATIVES AS MODULATORS OF KINASE ACTIVITY | 2014 |
|
RU2674261C2 |
| C-FMC KINASE INHIBITORS | 2007 |
|
RU2475483C2 |
